Vartika Chemicals And Pharmaceuticals Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
as on 15-05-2024
- Paid Up Capital ₹ 6.65 M
as on 15-05-2024
- Company Age 20 YEARS, 2 MONTHS
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 496.39 M
as on 15-05-2024
- Satisfied Charges ₹ 25.47 M
as on 15-05-2024
- Revenue 0.61%
FY 2021
- Profit 23.06%
FY 2021
- Ebitda 7.73%
FY 2021
- Net Worth 61.05%
FY 2021
- Total Assets 5.69%
FY 2021
About Vartika Chemicals And Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 6.65 M.
The company currently has active open charges totaling ₹49.64 Cr. The company has closed loans amounting to ₹2.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kamal Tripathi, Astha, and Vartika Tripathi serve as directors at the Company.
- CIN/LLPIN
U24232DL2004PTC127743
- Company No.
127743
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jul 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North East Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vartika Chemicals And Pharmaceuticals Private Limited offer?
Vartika Chemicals And Pharmaceuticals Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Vartika Chemicals And Pharmaceuticals?
Board Members(3)
Financial Performance and Corporate Structure Insights of Vartika Chemicals And Pharmaceuticals.
Vartika Chemicals And Pharmaceuticals Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 0.61% increase. The company also saw a substantial improvement in profitability, with a 23.06% increase in profit. The company's net worth Soared by an impressive increase of 61.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vartika Chemicals And Pharmaceuticals?
In 2021, Vartika Chemicals And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 18 Oct 2023 | ₹12.00 Cr | Open |
Hdfc Bank Limited Creation Date: 31 May 2022 | ₹3.05 M | Open |
Sidbi Creation Date: 07 Oct 2021 | ₹2.00 Cr | Open |
How Many Employees Work at Vartika Chemicals And Pharmaceuticals?
Vartika Chemicals And Pharmaceuticals has a workforce of 135 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Apr 21, 2016, Vartika Chemicals And Pharmaceuticals has raised a total of ₹ 7.33 M, with the most recent deal valued at ₹ 2.3 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
